Manuka Honey Inhibits Human Breast Cancer Progression in Preclinical Models
Manuka Honey Inhibits Human Breast Cancer Progression in Preclinical Models
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
Manuka honey (MH) exhibits potential antitumor activity in preclinical models of a number of human cancers. Treatment in vitro with MH at concentrations ranging from 0.3 to 5.0% (
/
) led to significant dose-dependent inhibition of proliferation of human breast cancer MCF-7 cells, but anti-proliferative effects of MH were less pronounced in M...
Alternative Titles
Full title
Manuka Honey Inhibits Human Breast Cancer Progression in Preclinical Models
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_3153724785
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3153724785
Other Identifiers
ISSN
2072-6643
E-ISSN
2072-6643
DOI
10.3390/nu16142369
